Related Articles
Development, efficacy and side effects of antibody‑drug conjugates for cancer therapy (Review)
Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells
Tyrosine kinase inhibitors in sarcoma treatment (Review)
Historical retrospective of the SRC oncogene and new perspectives (Review)
Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib